|
ZC3H18 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.89988041860079E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.51950005092772E-09 |
| Normal-vs-Stage2 |
2.597300E-03 |
| Normal-vs-Stage3 |
7.59790000000038E-05 |
| Normal-vs-Stage4 |
1.069970E-01 |
| Stage1-vs-Stage2 |
7.053600E-01 |
| Stage1-vs-Stage3 |
2.242400E-01 |
| Stage1-vs-Stage4 |
5.115200E-01 |
| Stage2-vs-Stage3 |
6.094000E-01 |
| Stage2-vs-Stage4 |
4.639600E-01 |
| Stage3-vs-Stage4 |
2.455200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.54081217071689E-13 |
| Normal-vs-AfricanAmerican |
3.59850000000161E-05 |
| Normal-vs-Asian |
2.515600E-01 |
| Caucasian-vs-AfricanAmerican |
3.037900E-02 |
| Caucasian-vs-Asian |
4.975600E-01 |
| AfricanAmerican-vs-Asian |
9.490400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.77617986563928E-12 |
| Normal-vs-Female |
1.22829999504859E-08 |
| Male-vs-Female |
5.504200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.395200E-04 |
| Normal-vs-Extreme_Weight |
9.99439997428908E-09 |
| Normal-vs-Obese |
3.78169999759592E-08 |
| Normal-vs-Extreme_Obese |
1.095200E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.445600E-01 |
| Normal_Weight-vs-Obese |
9.332400E-02 |
| Normal_Weight-vs-Extreme_Obese |
9.645200E-01 |
| Extreme_Weight-vs-Obese |
4.060000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.471800E-01 |
| Obese-vs-Extreme_Obese |
3.720400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.600660E-04 |
| Normal-vs-Age(41-60Yrs) |
1.03660413586226E-11 |
| Normal-vs-Age(61-80Yrs) |
5.55679946501186E-10 |
| Normal-vs-Age(81-100Yrs) |
2.760800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.790200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.254970E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.479200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.192400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.091600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.536300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.77315972805081E-15 |
| Normal-VS-Type2 PRCC |
1.494260E-02 |
| Normal-VS-KIRP CIMP |
2.013800E-02 |
| Normal-VS-Unclassified PRCC |
5.81089999451834E-08 |
| Type1 PRCC-VS-Type2 PRCC |
2.57970000028251E-07 |
| Type1 PRCC-VS-KIRP CIMP |
7.357200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.173800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.631950E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.45660000000036E-05 |
| KIRP CIMP-VS-Unclassified PRCC |
8.475400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.500200E-03 |
| Normal-vs-N1 |
3.97920000000385E-05 |
| Normal-vs-N2 |
8.418000E-01 |
| N0-vs-N1 |
3.216500E-02 |
| N0-vs-N2 |
3.712800E-01 |
| N1-vs-N2 |
6.340500E-02 |
|
|
